Company description

Compugen Ltd. (ticker symbol: CGEN) is a biopharmaceutical company that specializes in predictive discovery and development of novel drugs and therapeutic targets. The company utilizes proprietary computational biology technology to discover and analyze potential drug candidates and their targets. Compugen has a diverse portfolio of drug and therapeutic target candidates, including ones for cancer immunotherapy and autoimmune diseases. The company's unique approach has resulted in partnerships and collaborations with major pharmaceutical companies, further driving its growth and success. Additionally, Compugen has a strong track record of obtaining patents and commercializing its discoveries, making it a leader in the biopharmaceutical industry. With its commitment to innovation and expertise in computational biology, Compugen is poised to continue making groundbreaking advancements in the development of new treatments for various diseases.